Introduction {#Sec1}
============

The more we understand autism spectrum disorder and how it affects patients and their families, the easier it is to determine the support and resources required by each individual case. To understand what ASD is, in the current approach we should refer to the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5). Autism spectrum disorder is a set of neurodevelopmental disorders, which includes autistic disorder, Asperger's disorder and pervasive developmental disorder. It is characterized by the presence of deficits in social communication and social interaction across multiple contexts, and restricted, repetitive patterns of behavior, interests, or activities (APA [@CR4]). Diagnosis of ASD is based on comprehensive behavioral evaluations. Despite numerous studies, the etiology of ASD is unknown and remains the subject of speculations and misconceptions. Nevertheless, there is evidence of a strong influence of genes on the pathogenesis of ASD. Twin studies show that if one of a pair of identical twins meets the diagnostic criteria for ASD, the probability that the other will have the disorder is as high as 58% for boys and 60% for girls, while in the case of fraternal twins the probability falls to 21% for boys and 27% for girls (Hallmayer et al. [@CR30]). In order to get a thorough understanding of causes of ASD, numerous factors and their interactions have been examined (Szatmari et al. [@CR63]), including a number of genetic disorders (Xu et al. [@CR66]), anatomical brain abnormalities (cerebellum, brain stem, hippocampus, amygdale, and frontal lobes) (Belmonte et al. [@CR8]) and the comorbidities such as psychiatric, neurological, metabolic and gastrological disorders (Żurawicz et al. [@CR69]; Kałużna-Czaplińska et al. [@CR36], [@CR35]; McElhanon et al. [@CR51]).

Literature reports that parents of children with ASD experience increased psychological distress, including depression, anxiety, obsession-compulsion, interpersonal sensitivity, hostility, schizoid traits, paranoia, and schizophrenia (Karst and Van Hecke [@CR37]). Stressors refer to both family and social life and include emotional aspects of having a child with a disability, understanding a child's needs, various aspects of primary care, medical and education services as well as financial hardship (Gupta and Singhal [@CR29]; Tehee et al. [@CR64]). Because of the fact that children of different racial, socioeconomic and ethnic groups are affected by ASD and due to the scale of its prevalence, many problems related to ASD pose a challenge to the whole of society.

The aim of this paper was to present that the increasing prevalence of ASD has given this disorder a social dimension. Economic costs and other day-to-day problems of ASD patients and their families were described.

Prevalence and Social Aspect of ASD {#Sec2}
-----------------------------------

Epidemiological surveys provide the basis for awareness, planning policy and service needs, and offer the information necessary to identify potential risk factors for ASD. They also initiate the investigation of ASD prevalence in countries where such estimations have not yet been conducted. The earliest epidemiologic studies performed in the late 1960s according to Kanner's criteria indicated the prevalence of autism to be 0.5 per 1000 people among children in England (Lotter [@CR47]). Since then epidemiological studies of autism followed by ASD have been performed in various places worldwide. A summary of these studies is shown in Table [1](#Tab1){ref-type="table"}.

Table 1The prevalence rate of autism and ASDThe study periodPrevalence (per 1000)Geographical areaCriteriaMale to female ratioRef.19660.5EnglandKanner's criteria2.6Lotter ([@CR47])1966--19980.512 countries (UK, Germany, USA, Japan, Sweden, Ireland, Canada, France, Indonesia, Norway, Denmark, Iceland)12 different criteria3.8Fombonne ([@CR27])1987--19941.1CaliforniaDSM-III-R, DSM-IVNRCroen et al. ([@CR22])1990--199111.6UKICD-103.3Baird et al. ([@CR5])1994--199618.1JapanDSM-IV2.8Kawamura et al. ([@CR38])1994--199812.0IcelandICD-102.8Saemundsen et al. ([@CR60])19963.4USADSM-IV4.0Yeargin-Allsopp et al. ([@CR67])1996--20025.1NorwayICD-104.3Isaksen et al. ([@CR32])1997--20084.7USANRBoyle et al. ([@CR10])20006.7USADSM-IV-TR2.8--5.5CDC ([@CR13])20026.6USADSM-IV-TR3.4--6.5CDC ([@CR14])2003--200415.7UKICD-10NRBaron-Cohen et al. ([@CR6])2005--200926.4South KoreaDSM-IV2.5Kim et al. ([@CR39])20060.2ChinaICD-102.5Li et al. ([@CR44])20069.0USADSM-IV-TR3.2--7.6CDC ([@CR15])200711.0USADSM-IVNRKogan et al. ([@CR41])200811.3USADSM-IV-TR2.7--7.2CDC ([@CR16])201014.7USADSM-IV-TR4.5ADDM Network ([@CR1])20106.5IsraelDSM-IV5.2Davidovitch et al. ([@CR24])20108.0SwedenICD-104.0Nygren et al. ([@CR53])2011--201220.0USANR4.6Blumberg et al. ([@CR9])201214.6USANR4.5CDC ([@CR17])2011--201312.5USANRNRZablotsky et al. ([@CR68])201422.2USANRNRZablotsky et al. ([@CR68])

Data released in 2016 indicate the prevalence of ASD at 14.6 per 1000 (1 in 68) people among children in the USA. No change was noticed compared to the previous report published in 2014 (CDC [@CR18]). ASD can be diagnosed by age 2, yet in most children ASD was identified after age 4. Less than half of young patients were diagnosed with ASD by age 3 (ADDM Network [@CR2]).

According to the data, ASD is 1.2 times more likely among white children compared to black children. Additionally, it is more common in non-Hispanic white children (15.5 per 1000) than in non-Hispanic black children (13.2 per 1000) and Hispanic children (10.1 per 1000) (CDC [@CR16], [@CR18]; Christensen et al. [@CR19]).

As it is presented in Table [1](#Tab1){ref-type="table"}, the male-to-female prevalence ratio varies widely and ranges from 2.5 (Kim et al. [@CR39]; Li et al. [@CR44]) to 7.6 (CDC [@CR15]). It is not entirely clear how much of the increase in prevalence of ASD can be explained by a true expansion of the incidence or by other factors such as changes in the definition of ASD and diagnostic criteria, variations in research methodology as well as greater awareness and recognition.

A large impact of diagnostic criteria on the increasing rates of ASD is the result of the lack of definitive diagnostic tests for ASD. The diagnostic criteria are changing and developing with the evolution of the definition of ASD (King and Bearman [@CR40]; Fisch [@CR26]). Incompatibilities among diagnostic criteria may affect the interpretation of subgroups of ASD in epidemiological studies. This problem is particularly evident in Asperger's syndrome, for which the DSM-IV/ICD-10 criteria determine age-appropriate development of language, adaptive skills and curiosity, up to 3 years of age. The application of these criteria will result in significant differences in the diagnosis of Asperger's syndrome and autistic disorders than in the case of application of Gillberg's et al. criteria ([@CR28]). As it can be seen in Table [1](#Tab1){ref-type="table"}, the application of DSM or ICD diagnostic criteria in studies depends on the geographical region. Therefore, the comparison of the prevalence of ASD in Europe and in the United States can be difficult. There is a potential impact of the new DSM-5 criteria on the ASD prevalence and it is currently under consideration. Significant changes in these criteria include a complete removal of Rett's disorder and consolidation of autistic disorder, Asperger's disorder and pervasive developmental disorder into autism spectrum disorder, combination of socialization and communication deficits into one set of symptoms and extending the age criterion (APA [@CR4]; Matson and Kozlowski [@CR50]).

Despite the same diagnostic criteria, time frame and location, the application of a more thorough assessment may double the prevalence estimate within the same population. This may indicate the necessity for a careful selection of the research method (Posserud et al. [@CR58]). The differences in the research procedure may include terms of case-finding, sampling and diagnostic definitions (Baron-Cohen [@CR6]). It has been proved that the level of detail collected about and reviewed on children from multiple sources improves the result of estimates (CDC [@CR15]).

Considering the changes in the rates of ASD, increased awareness cannot be overlooked. Qualified professionals provide a proper diagnosis in accordance with current criteria. Whereas, increasing knowledge of ASD in a society may lead to a careful observation of disturbed behavior in children by their parents and, consequently, an early search for specialist advice. Their awareness began to rise from the 1960s along with the number of works on the nature of autism (Lotter [@CR48]; Rutter et al. [@CR59]; DeMyer [@CR25]). Nevertheless, until the 1980s autism was too little known to be located in a separate place in any of the ICD or DSM classifications. In1980 the term 'infantile autism' was introduced under the scope of a newly generalised category of 'pervasive developmental disorders' (PDD) (APA [@CR3]). A significant increase in the knowledge of autism began in the 1990s after the publication of the diagnostic interview schedule Autism Diagnostic Interview-Revised (ADI-R), which was originally used for research purposes (Lord et al. [@CR46]). Higher awareness is reflected in the growing amount of research funding available for ASD and the number of ASD research grants (Singh et al. [@CR62]). Figure [1](#Fig1){ref-type="fig"} shows a rapid increase in both the number of all published reports concerning ASD and research supported by the governments in the last decade.

Fig. 1Frequency of reports concerning ASD (1946--2016) Bibliographic research related to the use of term "autism or autistic" in records from the collection of PubMed database. In the search two sets of proceedings: with filters (Article types: Research Support, U.S. Government; Research Support, U.S. Gov't, P.H.S.; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't) and without any filter were applied. Results by year (as timeline) were downloaded in the CSV file. Records from 2017 were excluded from the timelines due to the lack of a full annual balance sheet

The role of mass media and all information campaigns conducted by various governmental and non-governmental organizations such as Centers for Disease Control and Prevention (Atlanta, USA), Autism-Europe (Brussels, Belgium) or Action for Autism (New Delhi, India) is very important. Thanks to them, the knowledge about ASD reaches a wide group of people.

Expenditure on Children with ASD {#Sec3}
--------------------------------

Due to the high incidence of ASD as well as a wide range of medical services required for affected children, the impact of ASD on the family and public budget is becoming increasingly important. Determination of expenditure related to ASD allows service planning, allocation of resources and appropriate changes in policy (Mandell et al. [@CR49]). Children with ASD have, on average, medical expenditures from 3 (Croen et al. [@CR23]) to even 9 (Mandell et al. [@CR49]; Peng et al. [@CR57]) times higher than other children.

Differences in the expenditure between children with ASD and other children largely come from total outpatient care, physician visits, and medications prescribed (Liptak et al. [@CR45]). The economic aspect can differ even between individuals with ASD and arise from personal needs connected with treatment, care and support. Costs often depend on age of the patients (Buescher et al. [@CR12]). Estimation of costs should also include the ability of parents of ASD children to work. The study has shown that mothers of patients with ASD have lower incomes than mothers of children with no health limitation. They are less likely to be employed and less likely to have full time jobs (Cidav et al. [@CR21]). The reason also lies in the difficulty in finding appropriate and affordable child care (Parish and Cloud [@CR54]).

In estimating the health care costs of children with ASD, the presence of co-occurring conditions should be taken into consideration. Almost half of the children with ASD can have one of the three co-occurring conditions (including attention deficit/hyperactivity disorder (ADHD), intellectual disability (ID) or epilepsy). Therefore, in children with ASD and one or more co-occurring conditions, average expenditures are even twice as high as in those with ASD without a co-occurring condition (Peacock et al. [@CR55]). It was also found that early intensive behavioral intervention for children with ASD affects long-term monetary savings for families and society (Jacobson et al. [@CR33]).

The costs associated with ASD can also directly affect the family of a child with ASD through family out-of-pocket expenses, including home and garden special adaptations, replacement and repair of house and content damages, specialist equipment (e.g. pushchairs and toys), training and seminars courses, travel, diet specialists, education materials. Half of the families of children with ASD report time off work due to their child's illness over the period of 6 months (Barrett et al. [@CR7]). The average loss of annual income among parents of children with ASD is even 14% of their reported income (Montes and Halterman [@CR52]). A summary of expenditures for children with ASD is presented in Table [2](#Tab2){ref-type="table"}. It should be noted that differences in expenditure among the USA, UK and China may result from differences in practice style and health care financing.

Table 2Expenditure on children with ASDCountry and year for costsAgeCost categories taken into accountStudy outcomeRef.USA (Pennsylvania) (1994--1999)0--21Health care costs\$9980 per yearMandell et al. ([@CR49])USA (North Dakota) (1998--2004)0--20Health care costs\$7894 per yearPeng et al. ([@CR57])USA (1999--2000)\< 19Health care costs\$6132 per yearLiptak et al. ([@CR45])UK (1999--2000)4--10Health care costs and non-health care costs£ 689 per weekJärbrink et al. [@CR34]USA (2000--2004)\< 18Health care costs\$5592 per yearLeslie and Martin ([@CR43])USA (2004)1--21Health care costs\$6830 per yearShimabukuro et al. ([@CR61])USA (California) (2003--2004)2--18Health care costs\$2757 per yearCroen et al. ([@CR23])USA (2003--2005)2--17Health care costs\$10,709 per yearPeacock et al. ([@CR55])USA (2005)≤ 15Loss of income of parents associated with having child with ASD\$6200 per yearMontes and Halterman ([@CR52])USA (2005)3--20Health care costs\$14,957 per yearCidav et al. ([@CR20])UK (2006--2007)2--4Health care costs and non-health care costs£ 3083 per 6 monthBarrett et al. ([@CR7])China (2007--2009)1--15Health care costsRMB 17,293 per yearWang et al. ([@CR65])USA (2011)NRHealth care costsHigher by \$4110--\$6200 per yearCDC ([@CR17])USA (2011)NRBehavioral intervention\$40,000--60,000 per yearCDC ([@CR17])

While a wide range of papers is focused on the childhood autism, its prevalence, costs and treatment, it is hard to find information about care system of adults with this disorder. The majority of reports refer to patients in the age range 3--17. This tendency clearly indicates how little attention is paid to individuals with ASD.

As ASD is characterized by social, communication and behavioral disabilities, their severity will influence the ability to work and live independently. The growing interest in the use of medical home model for adults with ASD can be seen. Yet, little is known about their availability (Bruder et al. [@CR11]). The health care status of adults with ASD is also neglected and concentrates mainly on the comorbid conditions (Koritsas and Iacono [@CR42]). It is reported that the vast majority of ASD patients is unable to live independently (Bruder et al. [@CR11]).

Conclusions and Directions for the Future {#Sec4}
-----------------------------------------

Autism spectrum disorder has a significant impact on the health care and finance systems and represents a challenge in the research planning. As it is shown in Fig. [1](#Fig1){ref-type="fig"}, the number of ASD research grants funded by the USA and non-USA governments in the last decade has significantly increased. In the USA, in the years 1997--2006 the majority of projects concentrated on basic science (65%) compared to clinical (15%) and translational research (20%) (Singh et al. [@CR62]). A very important area of research is an early detection of ASD.

To meet the concerns of adults with ASD, family members, practitioners and researchers, the areas that make a difference to people's day-to-day lives (e.g. effective public services, evidence-based interventions, programs to enhance individuals' life skills, understanding of the place of people with ASD in society) should be among the research priorities (Pellicano et al. [@CR56]).

High incidence of ASD increases problems with access to early diagnosis and intervention as well as economic issues associated with ASD, which in turn deepens the family crisis. Major challenges for the future of a child with ASD include education and the possibility of employment in adulthood (Pellicano et al. [@CR56]). All of these problems associated with ASD should find support in the legal system. In order to improve living conditions of children with ASD and their families, there is a need for the development of social policy in four key areas: health insurance, public funding policies which support evidence-based practices for ASD, federal policies and funding which support equal access to services, criteria for evidence-based practices, and research that meets the criteria for evidence-based practices (Howlin and Moss [@CR31]).

The progress observed in the last decade associated with the diagnosis, treatment, awareness, funding, as well as improving the functioning of the family of a child with ASD allows optimism in relation to the future. It should be noted that the research of ASD, physician activities, efforts to develop policies and raising awareness should be coordinated and the ethical issues should be taken into account.
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